159707-16-1

Basic information

• Product Name: (4S)-benzyl-3-[2'-(4-fluorophenyl)acetyl]-2-oxazolidinone
• Synonyms: (4S)-benzyl-3-[2'-(4-fluorophenyl)acetyl]-2-oxazolidinone
• CAS NO: 159707-16-1
• Molecular Weight: 313.328
• Mol File: 159707-16-1.mol
• Article Data: 15

Chemical Properties

• CAS DataBase Reference: (4S)-benzyl-3-[2'-(4-fluorophenyl)acetyl]-2-oxazolidinone(CAS DataBase Reference)
• NIST Chemistry Reference: (4S)-benzyl-3-[2'-(4-fluorophenyl)acetyl]-2-oxazolidinone(159707-16-1)
• EPA Substance Registry System: (4S)-benzyl-3-[2'-(4-fluorophenyl)acetyl]-2-oxazolidinone(159707-16-1)

Safety Data

• Hazardous Substances Data: 159707-16-1(Hazardous Substances Data)

Upstream product

• 90719-32-7 (S)-4-Benzyl-2-oxazolidinone 
• 459-04-1 4-Fluorophenylacetyl chloride 
• 144-55-8 sodium hydrogencarbonate 
• 3282-30-2 pivaloyl chloride 
• 70-07-5 mephenoxalone 
• 405-50-5 p-Fluorophenylacetic acid 

Downstream Products

• 191725-90-3 (S)-4-fluoro-α-methylphenylacetic acid 

Relevant articles and documents

INDANE DERIVATIVES AS MGLUR7 MODULATORS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4a and R4b are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds of formula (I) are mGluR7 modulators.

CERTAIN HETEROCYCLES, COMPOSITIONS THEREOF, AND METHODS FOR THEIR USE

Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, X, Z1, Z2, Z3, Z4 and m are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.

CARBOXY SUBSTITUTED CARBOXAMIDE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS

-